Larimar Therapeutics Inc (LRMR)
6.505
+0.12
(+1.80%)
USD |
NASDAQ |
Apr 19, 16:00
6.505
0.00 (0.00%)
After-Hours: 20:00
Larimar Therapeutics Market Cap: 415.02M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 407.68M |
| April 17, 2024 | 449.79M |
| April 16, 2024 | 461.91M |
| April 15, 2024 | 465.74M |
| April 12, 2024 | 444.05M |
| April 11, 2024 | 460.64M |
| April 10, 2024 | 436.39M |
| April 09, 2024 | 449.15M |
| April 08, 2024 | 460.64M |
| April 05, 2024 | 474.67M |
| April 04, 2024 | 463.83M |
| April 03, 2024 | 492.54M |
| April 02, 2024 | 469.57M |
| April 01, 2024 | 475.95M |
| March 28, 2024 | 484.24M |
| March 27, 2024 | 463.51M |
| March 26, 2024 | 459.36M |
| March 25, 2024 | 483.60M |
| March 22, 2024 | 516.14M |
| March 21, 2024 | 546.13M |
| March 20, 2024 | 544.21M |
| March 19, 2024 | 548.04M |
| March 18, 2024 | 532.73M |
| March 15, 2024 | 555.06M |
| March 14, 2024 | 554.74M |
| Date | Value |
|---|---|
| March 13, 2024 | 593.34M |
| March 12, 2024 | 559.53M |
| March 11, 2024 | 549.26M |
| March 08, 2024 | 649.19M |
| March 07, 2024 | 695.01M |
| March 06, 2024 | 715.38M |
| March 05, 2024 | 731.93M |
| March 04, 2024 | 726.84M |
| March 01, 2024 | 722.38M |
| February 29, 2024 | 731.93M |
| February 28, 2024 | 731.93M |
| February 27, 2024 | 747.20M |
| February 26, 2024 | 788.57M |
| February 23, 2024 | 771.39M |
| February 22, 2024 | 744.66M |
| February 21, 2024 | 765.66M |
| February 20, 2024 | 767.57M |
| February 16, 2024 | 813.39M |
| February 15, 2024 | 583.11M |
| February 14, 2024 | 525.15M |
| February 13, 2024 | 383.77M |
| February 12, 2024 | 343.81M |
| February 09, 2024 | 340.73M |
| February 08, 2024 | 275.75M |
| February 07, 2024 | 261.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
27.10M
Minimum
Aug 05 2022
813.39M
Maximum
Feb 16 2024
196.77M
Average
182.76M
Median
Market Cap Benchmarks
| Cogent Biosciences Inc | 640.13M |
| ACADIA Pharmaceuticals Inc | 2.771B |
| PTC Therapeutics Inc | 1.944B |
| Renovaro Inc | 310.32M |
| G1 Therapeutics Inc | 214.80M |
Market Cap Related Metrics
| Price to Book Value | 5.079 |
| Price | 6.505 |
| Earnings Yield | -12.91% |